Injectable PLA Microspheres With Uniform Size and Water Dispersibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

PLA microspheres in medical applications suffer from agglomeration, poor dispersibility in water, and inconsistent degradation rates, leading to challenges in injection and controlled drug release.

Innovation Solution

A preparation method involving spray drying of a solution comprising an oil phase with PLA, an organic solvent, and an aqueous phase with surfactants and macromolecular substances, followed by homogeneous emulsification and controlled drying conditions, results in uniform, injectable PLA microspheres with stable degradation rates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If traditional PLA microsphere preparation methods are used, then the microspheres can be formed, but they suffer from agglomeration and poor dispersibility in water, making them difficult to inject

Engineering Contradiction:
ImproveinjectabilityVSAvoiddispersibility
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent introduces surfactants as intermediary substances that mediate between the hydrophobic PLA microspheres and the aqueous environment. The surfactants adsorb onto the microsphere surfaces, providing hydrophilic groups that improve water dispersibility while maintaining microsphere integrity and injectability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies surface parameters of the PLA microspheres by controlling emulsification conditions, drying parameters, and surfactant concentrations. These parameter changes alter the surface properties to reduce agglomeration tendency and improve dispersibility without compromising the microspheric structure needed for injection.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If single PLA microspheres are used, then they can be prepared simply, but the degradation rate is slow in early stage and accelerates in later stage, which is not conducive to control of drug dosage

Engineering Contradiction:
Improvedegradation rate controlVSAvoidpreparation complexity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent creates composite microsphere systems by combining PLA with other materials during emulsification. This composite structure modifies the degradation profile to achieve more uniform drug release rates, preventing the burst release effect while maintaining manufacturing feasibility through integrated preparation processes.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent applies different materials or coatings to specific regions or surfaces of the microspheres to create localized properties that control degradation. This allows different parts of the microsphere system to degrade at different rates, achieving overall uniform drug release while keeping the bulk preparation process relatively simple.

Inventive Principle:
Principle #3Local quality

3Manufacturing precision

If homogeneous emulsification is performed at high rotational speed for extended time, then uniform microspheres are obtained, but production efficiency is reduced

Engineering Contradiction:
Improvemicrosphere uniformityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent performs preliminary emulsification at high speed to establish uniform droplet distribution, then maintains uniformity with lower speed agitation. This preliminary high-energy action creates the initial uniform structure that prevents aggregation during subsequent processing, reducing total processing time while maintaining microsphere uniformity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses periodic or pulsed emulsification cycles with alternating high and low speed phases. The high-speed pulses create uniform droplets periodically, while lower-speed intervals allow controlled coalescence and reduce energy consumption, achieving uniform microspheres with improved overall production efficiency.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces microspheres with controlled particle sizes, good biocompatibility, and consistent degradation rates, enabling effective drug delivery and mass production, overcoming issues of agglomeration and inconsistent release.

Implementation Method 1

performing homogeneous emulsification on the spray solution to obtain an emulsified spray solution

Methodology Applied
Scientific EffectEmulsification: Emulsion

Implementation Method 2

drying the emulsified spray solution to obtain the injectable PLA microspheres

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentEP4696304A1Preparation method for injectable PLA microspheres, and use thereof
Publication Date: 2026.02.18 ESUNMED BIOTECHNOLOGY (SHENZHEN) CO LTD
  • EP4696304A1 patent drawingFigure 1
  • EP4696304A1 patent drawing
  • EP4696304A1 patent drawing

AI summary

A preparation method and an application of injectable polylactic acid (PLA) microspheres are provided, which relate to the field of biomedical technologies. The preparation method of the injectable PLA microspheres include: S01, preparing a spray solution; S02, performing homogeneous emulsification on the spray solution to obtain an emulsified spray solution; and S03, drying the emulsified spray solution. The spray solution includes an oil phase and an aqueous phase, and a weight ratio of the oil phase and the aqueous phase is 1-10 : 1-10. The oil phase includes PLA and an organic solvent, and the aqueous phase includes a surfactant, macromolecular substances and deionized water. A particle size of the injectable PLA microspheres is basically below 60 µm, and the injectable PLA microspheres have a complete form, are independent of each other, do not exhibit agglomeration and have good biocompatibility, which can satisfy the requirement of the injection.